Viking Therapeutics Stock Forecast 2021
Viking therapeutics inc has risen higher in 2 of those 6 years over the subsequent 52 week period, corresponding to a historical accuracy of 33.33 % 26, 2020 when the stock price was at 8.11$.
With the market capitalization of viking therapeutics inc.
Viking therapeutics stock forecast 2021. Viking therapeutics last posted its earnings data on november 3rd, 2021. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Close price at the end of the last trading day (wednesday, 1st dec 2021) of the vktx stock was $5.02.
View analysts' price targets for viking therapeutics or view. Vktx) is scheduled to announce q3 earnings results on wednesday, november 3rd, after market close. Everything about viking therapeutics inc's forecasts and estimates, including earnings per share, sales, earnings trends for 2021, 2022, etc.
During the day the stock fluctuated 8.37% from a day low at $5.02 to a day high of $5.44. Viking therapeutics recently reported their q1 earnings that revealed the company still has a strong cash position to help fund their impressive pipeline. Vktx stock forecast our latest prediction for viking therapeutics inc's stock price was made on the aug.
273 rows viking therapeutics inc stock price forecast, vktx predictons for2022 On average, they expect viking therapeutics' stock price to reach $15.57 in the next year. The average price target represents a 170.16% change from the last price of $6.20.
This is 5.46% less than the trading day before tuesday, 30th nov 2021. Based on 5 wall street analysts offering 12 month price targets for viking therapeutics in the last 3 months. This suggests a possible upside of 174.6% from the stock's current price.
For viking therapeutics stock forecast 2022, 12 predictions are offered for each month of 2022 with average viking therapeutics stock forecast of $5.01, a high forecast of $5.41, and a low forecast of $4.71. Viking therapeutics inc stock forecast. Viking therapeutics may not be the best stock to buy.so take a peek at this free list of interesting companies with high roe and low debt.
In the medium term (3months), vktx's stock price should underperform the market by. Vktx) is owned by 48.27% institutional shareholders, 11.87% viking therapeutics insiders, and 39.85% retail investors. Get the hottest stocks to trade every day before the market.
The company report on april 29, 2021 that viking therapeutics reports first quarter 2021 financial results and provides corporate update. Over the next 52 weeks, viking therapeutics inc has on average historically risen by 54 % based on the past 6 years of stock performance. Viking therapeutics q3 2021 earnings preview.
The biotechnology company reported ($0.17) eps for the quarter, topping the consensus estimate of ($0.21) by $0.04. Their forecasts range from $13.00 to $21.00. For the purposes of this article, insiders are.
116 rows viking therapeutics inc stock forecast, vktx stock predictons by days: Viking therapeutics has generated ($0.71) earnings per share over the last year (($0.71) diluted earnings per share). Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock.
Press release reported on 03/04/21 that viking therapeutics to participate at upcoming investor conferences. The average price target is $16.75 with a high forecast of $20.00 and a low forecast of $14.00. Pharmaceuticals inc ligand is the largest individual viking therapeutics shareholder, owning 5.82m shares representing 7.44% of the company.
Post a Comment for "Viking Therapeutics Stock Forecast 2021"